Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
Antibody Licensing Opportunities From a One-of-a-Kind Discovery Engine
Antibodies continue to expand the boundaries of druggable targets and treatable diseases. Yet bringing a biologic to market, even one that promises to be first- or best-in-class, is filled with preclinical and clinical obstacles that can’t be overcome alone.
At Twist Biopharma Solutions, we're seeking partnerships with academic, biotech, and biopharma teams to help us translate lead assets from our unique discovery and optimization platform into clinical successes. Through close collaboration, we can break the shackles off of hard-to-drug targets in strategic therapeutic areas, ensuring that no disease is labeled “untreatable” and no patient is left behind.
Our Therapeutic Focus
With our discovery, optimization, and characterization capabilities as our foundation, we’ve made expanding your pipeline in important indications simple.
Our Asset Pipeline
Our pipeline is dedicated to tackling challenging targets and discovering high-potential assets with promising pharmacology. With our end-to-end antibody development capabilities, we’ve assembled promising preclinical data packages to springboard you into the clinic.
Schedule a meeting to learn more about our flexible partnering options and data packages for asset licensing.
Why partner with Twist?
Interested in hearing more about our unique antibody licensing opportunities?
Partner with Twist Biopharma Solutions to shape the future of antibody therapeutics. Our de-risked preclinical assets bring promise and potential to your pipeline. They are the product of our best-in-class discovery, optimization, and characterization platforms. See how we can help unlock new opportunities and strategic positioning in biopharma.
Get in Touch With Us
Antibody enthusiasts are standing by and would love to hear more about your discovery needs. Challenging targets welcome!
